IP Group has joined forces with tech transfer company Crossword Cybersecurity to target the launch of more cybersecurity spinouts.
Biontech, an immunotherapy spinout of Johannes Gutenberg University Mainz, has received an undisclosed amount of equity funding as part of a collaboration deal that could reach $425m.
Ambys Medicines has raised $60m in a series A round backed by Takeda and signed a strategic partnership agreement with the corporate worth $80m.
Scripps Research Institute spinout BlackThorn Therapeutics will use Yale's Gemini-Dot technology to identify drug targets for neurobehavioural disorders.
Frontier IP has partnered the UK Department for International Trade to establish support and networking opportunities in the country.
Multi-million-dollar investments by Anges will help Vasomune progress its peptide-based therapy for blood vessel-related diseases to the clinic.
University of Chicago and Northwestern University have drawn more funds from a JP Morgan Chase initiative designed to support inner-city entrepreneurship and underrepresented groups.
University-Industry Demonstration Partnership brought together delegates for its 26th and biggest conference to date this past April.